Page last updated: 2024-09-05

em 523 and devazepide

em 523 has been researched along with devazepide in 1 studies

Compound Research Comparison

Studies
(em 523)
Trials
(em 523)
Recent Studies (post-2010)
(em 523)
Studies
(devazepide)
Trials
(devazepide)
Recent Studies (post-2010) (devazepide)
2610780542

Protein Interaction Comparison

ProteinTaxonomyem 523 (IC50)devazepide (IC50)
Bile salt export pumpHomo sapiens (human)10
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.0009
Gastrin/cholecystokinin type B receptorRattus norvegicus (Norway rat)0.0008
Cholecystokinin receptor type AHomo sapiens (human)0.0002
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.245
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)0.27

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, H1

Reviews

1 review(s) available for em 523 and devazepide

ArticleYear
[Receptor agonists and antagonists: the present and future].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1993, Volume: 38, Issue:11

    Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzodiazepinones; Biphenyl Compounds; Cholinergic Antagonists; Devazepide; Erythromycin; Imidazoles; Ligands; Losartan; Peptides; Receptors, Cholecystokinin; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Tetrazoles

1993